501-3292
Production Way, Burnaby, B.C., V5A 4R4
Phone:
(604) 551-7831 Fax:
604-676-2767
info@cannabixtechnologies.com
cannabixtechnologies.com
Cannabix
Technologies Provides
Update on THC
Breath Analyzer Development
and Testing
Cannabix
is developing
Marijuana
Breathalyzer
devices to
give law enforcement and employers
a
tool to
enhance
public safety
Vancouver, British
Columbia -- August
13, 2020
--
InvestorsHub NewsWire -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the "Company or Cannabix")
developer
of the Cannabix Marijuana Breathalyzer for law enforcement and the
workplace, is pleased to report
that
it
has been
performing
user
testing with human subjects in
Vancouver, BC
with
its version
2.0 THC Breath Analyzer
("THCBA"). The THCBA device
currently provides results in under five minutes. Cannabix
has been
testing
the THCBA device with
positive and negative cannabis breath samples
with the
objective of further training
the device's machine
learning database and optimizing
components for its
upcoming (more robust)
version
3.0 device. In recent
weeks, Company
engineers have also been
focusing on device scalability, reducing device production
costs,
and
have tested new
thermoplastic soft molded components that would allow for higher
durability, and
reproducibility.
Additional
sensors
are being incorporated
into
the device
that
will
integrate
more
breath
sample meta-data and will allow for device
usage under a wider range of
environmental conditions. Engineers have
also
developed
a technique for sanitization of the device between
users, and the GUI for the
device has been simplified for administrators.
Many of
these improvements
have
been
incorporated
into
the
current device and other improvements
are scheduled
to be
included into a version 3.0
device that will undergo
more
widespread pilot
use. Recent pictures of
user testing activity with the THCBA version 2.0
are
included
in this press release and available on the Company's website
at
www.cannabixtechnologies.com.
.jpg)
The user
testing procedure includes a
baseline breath sample
prior
to the subject
smoking
cannabis followed by
samples
taken
after smoking cannabis at multiple time points up to
a minimum
of 2
hours.
Newly
available images show
how
a subject
interacts
with the device
at
various stages of use. The testing
process includes a sampling
stage,
an
analysis
stage, and
the
results stage - showing when
THC
is
detected
(a positive
result)
and
when
THC
is
not
detected (a negative
result).
The
THCBA incorporates
microfluidic sensor technology for the detection of
THC
from
breath. The Company has been
developing the THCBA with Dr. Mina Hoorfar at University of British
Columbia Okanagan
campus ("UBC") and has an
exclusive technology license agreement with UBC.
Cannabix
Technologies is
on the
forefront in research and
development to create
point-of-care
breath
testing
technologies for
the
detection of ?9-tetrahydrocannabinol
("THC") - the psychoactive
component of marijuana that causes impairment.
About
Cannabix Technologies Inc.
Cannabix
Technologies Inc. is a leader in marijuana breathalyzer development
for law enforcement and the workplace. Cannabix has established
breath testing technologies in the pursuit of bringing
accurate,
durable,
portable tools to market to enable
detection
of marijuana-impaired driving
offences on roads at a time when marijuana is becoming legal in
many global jurisdictions. Cannabix is working to develop
drug-testing devices that will detect THC- the psychoactive
component of marijuana that causes intoxication- using breath
samples. In particular, Cannabix is focused on developing breath
testing devices for detection of recent use of THC, in contrast to
urine testing for THC metabolite that requires an invasive
collection and reflects usage, days or even weeks earlier. The
devices will also be useful for other practical applications such
as testing employees in the workplace where impairment by THC can
be hazardous.
We seek
Safe Harbor.
On
behalf of the Board of Directors
"Rav
Mlait"
CEO
Cannabix
Technologies Inc.
For
further information, contact the Company at
info@cannabixtechnologies.com
The
CSE has not reviewed and does not accept responsibility for the
adequacy or accuracy of this release.
Cautionary Statement
Regarding Forward-Looking Statements
This
press release contains forward-looking information that involves
various risks and uncertainties regarding future events. Such
forward-looking information can include without limitation
statements based on current expectations involving a number of
risks and uncertainties and are not guarantees of future
performance of the Company, such as final development of a
commercial or prototype product(s), successful trial or pilot of
company technologies, no assurance that commercial sales of any
kind actually materialize; no assurance the Company will have
sufficient funds to complete product development. There are
numerous risks and uncertainties that could cause actual results
and the Company's plans and objectives to differ materially from
those expressed in the forward-looking information, including:
(i) adverse market
conditions; (ii) risks regarding protection of proprietary
technology; (iii) the ability of the Company to complete
financings; (iv) the ability of the Company to develop and market
its future product; and (v) risks regarding government regulation,
managing and maintaining growth, the effect of adverse publicity,
litigation, competition and other factors which may be identified
from time to time in the Company's public announcements and
filings. There is no assurance that the marijuana breathalyzer
business will provide any benefit to the Company, and no assurance
that any proposed new products will be built or proceed. There is
no assurance that existing "patent pending" technologies licensed
by the Company will receive patent status by regulatory
authorities. The Company is not currently selling commercial
breathalyzers. Actual results and future events could differ
materially from those anticipated in such information. These and
all subsequent written and oral forward-looking information are
based on estimates and opinions of management on the dates they are
made and are expressly qualified in their entirety by this notice.
Except as required by law, the Company does not intend to update
these forward-looking statements.
